Stephen Tulipano

Track

Insider profile

Currently holds a position at Stoke Therapeutics Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -91% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Stoke Therapeutics Inc March 1, 2019 -
Chief Financial Officer, Treasurer Aldeyra Therapeutics Inc June 23, 2014 - July 27, 2018
Stephen Tulipano's trades of Stoke Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
212.90
Quantity 75,344 -46.1%
Value US$3,693,665
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-19 2024-03-19
S Sale
1,408 +42.0%
453.27
US$2,032,324 		1,408 +42.0% 453.27 US$2,032,324
2021-02-24 2021-02-23
PlS Planned sale
75,344 -46.1%
212.90
US$3,693,665 		75,344 -46.1% 212.90 US$3,693,665
2021-02-24 2021-02-22
PlS Planned sale
16,403 -0.2%
487.61
US$604,544 		16,403 -0.2% 487.61 US$604,544
2021-02-24 2021-02-22
PlS Planned sale
9,696 -93.2%
59.29
US$574,842 		9,696 -93.2% 59.29 US$574,842
2021-02-24 2021-02-22
PlS Planned sale
15,202 -59.4%
58.67
US$891,942 		15,202 -59.4% 58.67 US$891,942
2020-11-04 2020-11-04
PlS Planned sale
5,216 -89.7%
41.97
US$218,910 		5,216 -89.7% 41.97 US$218,910
2020-11-04 2020-11-04
PlS Planned sale
11,111 -65.6%
41.42
US$460,214 		11,111 -65.6% 41.42 US$460,214
2020-11-04 2020-11-04
PlS Planned sale
16,941 -50.0%
40.03
US$678,086 		16,941 -50.0% 40.03 US$678,086
2020-11-04 2020-11-03
PlS Planned sale
1,732 -74.2%
39.84
US$68,998 		1,732 -74.2% 39.84 US$68,998
2020-11-04 2020-11-02
PlS Planned sale
400 -39.9%
38.44
US$15,374 		400 -39.9% 38.44 US$15,374
2020-11-04 2020-11-02
PlS Planned sale
14,445 -93.5%
37.86
US$546,909 		14,445 -93.5% 37.86 US$546,909
2020-11-04 2020-11-02
PlS Planned sale
20,155 -56.6%
36.79
US$741,448 		20,155 -56.6% 36.79 US$741,448